This list is an analysis based on recent market events. It's not an investment recommendation.
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
FAQs
What is Medeon Biodesign stock price today?▼
The current price of 6499.TWO is TWD71.30 TWD — it has decreased by -3.26% in the past 24 hours. Watch Medeon Biodesign stock price performance more closely on the chart.
What is Medeon Biodesign stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Medeon Biodesign stocks are traded under the ticker 6499.TWO.
Is Medeon Biodesign stock price growing?▼
6499.TWO stock has fallen by -7.64% compared to the previous week, the month change is a -10.65% fall, over the last year Medeon Biodesign has showed a -28.7% decrease.
What is Medeon Biodesign market cap?▼
Today Medeon Biodesign has the market capitalization of 6.91B
When is the next Medeon Biodesign earnings date?▼
Medeon Biodesign is going to release the next earnings report on March 4, 2027.
What is Medeon Biodesign revenue for the last year?▼
Medeon Biodesign revenue for the last year amounts to 585.62M TWD.
What is Medeon Biodesign net income for the last year?▼
6499.TWO net income for the last year is -1.61B TWD.
Does Medeon Biodesign pay dividends?▼
Yes, 6499.TWO dividends are paid annual. The last dividend per share was 0.48 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Medeon Biodesign have?▼
As of November 3, 2026, the company has 1,496 employees.
In which sector is Medeon Biodesign located?▼
Medeon Biodesign operates in the Health & Wellness sector.
When did Medeon Biodesign complete a stock split?▼
The last stock split for Medeon Biodesign was on August 23, 2023 with a ratio of 1049.9928649:1000.
Where is Medeon Biodesign headquartered?▼
Medeon Biodesign is headquartered in Taipei, Taiwan.